Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
08/2010
08/26/2010US20100216829 Method and compositions for deterring abuse of opioid containing dosage forms
08/26/2010US20100216823 Spirocyclic Derivatives
08/26/2010US20100216821 Benzimidazoles With A Hetero Spiro-Decane Residue As NPY-Y5 Antagonists
08/26/2010US20100216816 Pyrazinyl amide-t type calcium channel antagonists
08/26/2010US20100216815 N-substituted oxindoline derivatives as calcium channel blockers
08/26/2010US20100216814 Pyrido[4,3-b]indoles containing rigid moieties
08/26/2010US20100216812 Cyclopropyl Amide Derivatives
08/26/2010US20100216808 Substituted pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
08/26/2010US20100216807 Heterocyclic compounds as serotonergic and / or dopaminergic agents and uses thereof
08/26/2010US20100216805 Modulation of neurogenesis using d-cycloserine combinations
08/26/2010US20100216801 Thiazolones for use as pi3 kinase inhibitors
08/26/2010US20100216790 Imidazopyridine-derivatives as inducible no-synthase inhibitors
08/26/2010US20100216789 Rho-kinase inhibitors
08/26/2010US20100216785 Pharmaceutical compositions
08/26/2010US20100216784 Compounds for Inhibiting Beta-Amyloid Production and Methods of Identifying the Compounds
08/26/2010US20100216783 Compositions, synthesis, and methods of utilizing arylpiperazine derivatives
08/26/2010US20100216781 mTOR KINASE INHIBITORS FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCIATED WITH THE mTOR/PI3K/AKT PATHWAY
08/26/2010US20100216780 Novel 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives and their medical use
08/26/2010US20100216775 Adamantanamines and Neramexane Salts of Thiomolybdic and Thiotungstic Acids
08/26/2010US20100216771 Method oftreating demyelination diseases
08/26/2010US20100216765 Kinase inhibitors
08/26/2010US20100216763 Heteroaryl Amide Derivatives
08/26/2010US20100216762 Agonists and Antagonists of the S1P5 Receptor, and Methods of Use Thereof
08/26/2010US20100216758 Pyridone Compounds
08/26/2010US20100216756 Compositions and methods for suppressing endometrial proliferation
08/26/2010US20100216752 Use as medicaments of derivatives of cholest-4-en-3-one, pharmaceutical compositions containing them, novel derivatives and their preparation process
08/26/2010US20100216750 Tricyclic inhibitors of fatty acid amide hydrolase
08/26/2010US20100216749 Combination Therapy for Neuroprotection
08/26/2010US20100216748 Pyrrole Derivatives and Their Methods of Use
08/26/2010US20100216740 Cereal-based Infant Nutrition with Fibre
08/26/2010US20100216735 Gpcr enhanced neuroprotection to treat brain injury
08/26/2010US20100216734 Modulation of neurogenesis by nootropic agents
08/26/2010US20100216726 Substituted-Quinoxaline-Type Piperidine Compounds and the Uses Thereof
08/26/2010US20100216723 Neuroprotection using nap-like and sal-like peptide mimetics
08/26/2010US20100216722 Use of the peptide pro-gly-thr-cys-glu-ile-cys-ala-tyr-ala-ala-cys-thr-gly-cys as a therapeutic agent
08/26/2010US20100216716 Cell-Permeable Peptide Inhibitors Of The JNK Signal Transduction Pathway
08/26/2010US20100216710 Methods for stimulating nervous system regeneration and repair by regulating arginase i and polyamine synthesis
08/26/2010US20100216709 Systemic insulin-like growth factor-1 therapy reduces diabetic peripheral neuropathy and improves renal function in diabetic nephropathy
08/26/2010US20100216706 Ghrelin Protects Substantia Nigra Dopamine Neurons
08/26/2010US20100216698 Liquid formulations of g-csf
08/26/2010US20100215786 Morinda citrifolia enhanced lip treatment
08/26/2010US20100215774 Film comprising nitroglycerin
08/26/2010US20100215771 Use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy
08/26/2010US20100215759 Pharmaceutical compounds
08/26/2010US20100215742 Drug active in neuropathic pain
08/26/2010US20100215741 Pharmaceutical compounds
08/26/2010US20100215740 Taste-masked orally disintegrating tablets of memantine hydrochloride
08/26/2010US20100215739 Low dose topiramate / phentermine composition and methods of use thereof
08/26/2010US20100215737 Combination pharmaceutical compositions
08/26/2010US20100215735 Compounds for Inhibiting Beta-Amyloid Production and Methods of Identifying the Compounds
08/26/2010US20100215722 Tissue Regeneration II
08/26/2010US20100215667 Methods and compositions of treatment for modulating the immune system of animals
08/26/2010US20100215663 Methods and compositions for regulation of neurological conditions
08/26/2010US20100215661 Nicotinamide derivates useful as p38 inhibitors
08/26/2010US20100215657 Methods and Compositions Using Klotho-FGF Fusion Polypeptides
08/26/2010US20100215652 Nicotinamide derivates useful as p38 inhibitors
08/26/2010US20100215650 Methods of treating dementia using a gm-csf antagonist
08/26/2010US20100215637 Agent for the Treatment of Hormone-Dependent Disorders and Uses Thereof
08/26/2010US20100215636 Peptides derived from plasminogen activator inhibitor-1 and uses thereof
08/26/2010US20100215631 Anti-inflammatory composition comprising glycine and lactoferrin and the use thereof
08/26/2010US20100215579 Phen-naphthalene and phen-quinoline derivatives and their use for binding and imaging amyloid plaques
08/26/2010CA2753034A1 Methods of and compositions for reducing cell death
08/26/2010CA2752807A1 Amine or amino alcohols as glyt1 inhibitors
08/26/2010CA2752796A1 Cyclopropyl amide derivatives targeting the histamine h3 receptor
08/26/2010CA2752720A1 Hydrogel of polysaccharide derivative
08/26/2010CA2752596A1 Tetrahydrothiazolopyridine inhibitors of phosphatidylinositol 3-kinase
08/26/2010CA2752373A1 Glutathione-based drug delivery system
08/26/2010CA2752171A1 Method for inhibiting neurodegeneration
08/26/2010CA2750993A1 Carboxamide compounds and their use as calpain inhibitors
08/26/2010CA2749867A1 Heteroaryl substituted pyridazinone derivatives
08/26/2010CA2749649A1 Isoxazole-isoxazole and isoxazole-isothiazole derivatives
08/26/2010CA2749495A1 Novel substituted benzoxazole, benzimidazole, oxazolopyridine and imidazopyridine derivatives as gamma secretase modulators
08/26/2010CA2748701A1 Pyrrolidine derivatives as nk3 receptor antagonists
08/26/2010CA2745657A1 Extended length botulinum toxin formulation for human or mammalian use
08/26/2010CA2741984A1 Novel and potent tapentadol dosage forms
08/25/2010EP2221308A1 Benzazepinone compound
08/25/2010EP2221307A1 Purine derivatives as adenosine A1 receptor agonists and methods of use thereof
08/25/2010EP2221301A1 Heteroaryloxy quinazoline derivative
08/25/2010EP2221296A1 Fused indane compound
08/25/2010EP2221064A1 Humanized antibodies that recognize beta amyloid peptide
08/25/2010EP2221058A1 Antimelancholic medicine prepared with jujube camp materials
08/25/2010EP2221057A1 Sense-improving agent
08/25/2010EP2221047A1 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
08/25/2010EP2220083A2 Imidazo[1,2-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
08/25/2010EP2220074A1 3,5-substituted indole compounds having nos and norepinephrine reuptake inhibitory activity
08/25/2010EP2220066A1 Benzofuran anilide histone deacetylase inhibitors
08/25/2010EP2220060A1 Medicaments
08/25/2010EP2220053A1 Arylindenopyrimidines and their use as adenosine a2a receptor antagonists
08/25/2010EP2220045A1 Substituted pyridyl amide compounds as modulators of the histamine h3 receptor
08/25/2010EP2220037A1 Synthetic sphingolipid analogs
08/25/2010EP2220030A2 4- (p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
08/25/2010EP2220029A1 Novel compounds
08/25/2010EP2220027A1 New polymorphic forms of n-ý4-(trifluoromethyl)benzyl¨-4-methoxybutyramide
08/25/2010EP2219661A1 Compositions for tissue repair/regeneration
08/25/2010EP2219649A2 Use of mnk inhibitors for the treatment of alzheimer's disease
08/25/2010EP2219648A1 Treatment of post-traumatic stress disorder with tetrahydroindolone arylpiperazine compounds
08/25/2010EP2219647A1 Therapeutic uses of compounds having combined sert, 5-ht3 and 5-ht1a activity
08/25/2010EP2219634A1 Pharmaceutical for the treatment of phantom phenomena
08/25/2010EP2219629A1 Novel compounds as cannabinoid receptor ligands
08/25/2010EP2219450A1 Alleviating neuropathic pain with eets and seh inhibitors
1 ... 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 ... 1833